
Paulo Rosito
Paulo Rosito
Professional experience
Paulo Rosito has more than 25 years of experience acting as an in-house counsel in legal departments of big companies of the pharmaceutical, agribusiness and aviation areas, with time spent on private practice in the intellectual property area. He acts strategically in consultive and litigation cases of the Life Sciences area, especially in governmental interactions and relations with a variety of authorities, for example, ANVISA (Brazilian regulatory agency), CMED (Brazilian pharmaceutical price authority) and CONITEC (the Brazilian health technology assessment instrumentality). Due his vast experience, he has worked in a number of negotiation, drafting and review of agreements and contracts both strategic or routine and has an extensive experience in all areas of compliance, such as structuring of policies and procedures (SOPs), investigations and multidisciplinary legal advice.
Education
- Specialist in Corporate Law by PUC-SP (2000).
- Law Decree by PUC-SP (1998).
Publications
- Temas 6 e 1234: uma possível luz no fim do túnel aos pacientes raros Jota, 2025
- Anvisa aprova Consulta Pública para atualizar a regulamentação de produtos de cannabis – Souto Correa Advogados Souto Correa, 2025
- Cânhamo Industrial: STJ Reitera Obrigação da Anvisa de Regulamentar o Tema até Maio de 2025 – Souto Correa Advogados Souto Correa, 2025
- Conselho Nacional de Saúde publica regulamentação de banco de dados em Pesquisa Clínica – Souto Correa Advogados Souto Correa, 2025
Additional Activities
- Member of the Board of Directors of Blue Health Participações S.A. (2022-2023)
- Guest Professor at Seton Hall University in the Latin America Healthcare Compliance Certificate Program.
Recognitions



related content
-
Client Alert
Legislative Update: Promulgation of Vetoed Provisions of the Clinical Research Law
07/07/2025
-
Client Alert
Updates on the 17 Trends for the Healthcare Market in 2025
23/06/2025
-
Client Alert
Brazilian National Congress Overturns Presidential Veto of the New Legal Framework for Clinical Trials with Humans
18/06/2025